选择性IgA缺乏症患者中神经疾病的患病率
Eli Magen1, Akim Geishin1, Eugene Merzon1
1From the Leumit Health Services, Tel Aviv-Yafo, Israel.
Allergy and asthma proceedings
|August 29, 2023
概括
选择性免疫球蛋白A缺乏症 (sIgAD) 与更高的自闭症和动作障碍率有关. 在以色列的一项大型研究中,这种情况显示偏头痛的患病率较低,但的患病率较高.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 流行病学 流行病学
背景情况:
- 没有先前的流行病学研究检查了选择性免疫球蛋白A缺乏症 (sIgAD) 中的神经系统疾病的患病率.
- 了解这种关联对于识别免疫功能与神经疾病之间的潜在联系至关重要.
研究的目的:
- 确定以色列人口中被诊断患有sIgAD的各种神经疾病的流行率.
- 为了比较sIgAD个体与匹配的对照组之间的这些条件的发生率.
主要方法:
- 一项基于人口的病例控制研究使用来自以色列大型卫生维护组织 (>700,000名成员) 的数据进行.
- 这项研究包括796名sIgAD患者 (血清IgA<0.07g/L,年龄≥4) 和3980名匹配对照 (1:5比).
- 匹配标准包括年龄,性别,种族和社会经济地位.
主要成果:
- 患有sIgAD的个体表现出更高的自闭症谱系障碍和动障碍的患病率.
- 与对照组相比,sIgAD组中偏头痛的发病率较低 (2.39%) (4.22%),或0.55 (95% CI,0.34-0.90).
- 病例在sIgAD组 (1.76%) 比对照组 (0.80%) 更频繁,或2.28 (95% CI,1.12-4.44).
结论:
- 这些发现表明,免疫球蛋白A (IgA) 在非传染性中枢神经系统疾病中可能发挥作用.
- 需要进一步进行基础研究,以阐明SIgAD与特定神经疾病之间的观察到的关联.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
354
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
Irritable Bowel Syndrome I: Introduction
311
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
311
Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
188
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
188
Transcytosis of IgG
2.8K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K


